Clinical Trials List
2024-11-12 - 2030-12-19
Phase III
Recruiting7
ICD-10M35.00
Sicca syndrome, unspecified
ICD-10M35.01
Sicca syndrome with keratoconjunctivitis
ICD-10M35.09
Sicca syndrome with other organ involvement
ICD-9710.2
Sicca syndrome
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chien-Chih Lai 風濕免疫科
- Yi-Syuan Sun 風濕免疫科
- Ming-Han Chen 風濕免疫科
- Hsien-Tzung Liao 風濕免疫科
- 蔡弘正 風濕免疫科
- 曹彥博 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ping-Han Tsai Division of Rheumatology
- 蕭朝陽 Division of Rheumatology
- 陳彥輔 Division of Rheumatology
- 張哲慈 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王恭宇 風濕免疫科
- 藍鼎淵 風濕免疫科
- CHENG-HAN WU 風濕免疫科
- 林冠言 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
49 participants
-
Global
600 participants
